ADMA Biologics
ADMA
ADMA
94 hedge funds and large institutions have $88.7M invested in ADMA Biologics in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $110M → $88.7M (-$21.6M)
42% less call options, than puts
Call options by funds: $1.15M | Put options by funds: $1.97M
Holders
94
Holding in Top 10
–
Calls
$1.15M
Puts
$1.97M
Top Buyers
| 1 | +$734K | |
| 2 | +$678K | |
| 3 | +$645K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$517K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$389K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$1.6M | |
| 3 | -$982K | |
| 4 |
Goldman Sachs
New York
|
-$639K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$478K |